Analgesics in Algeria - New Market Research Report

Prior to the review period, the Algerian government imposed strict controls on pharmaceutical imports. However, there was insufficient domestic production capacity to meet growing demand for analgesics for much of the review period. From 2011, the government thus began to invest in expanding domestic production, particularly via Saidal, which is majority state-owned. The government also eased import restrictions in the last two years of the review period, further improving the supply of analgesics.

Competitive Landscape

Sanofi-Aventis is the clear leader in analgesics, accounting for over 35% value share in 2014. The company benefits from offering strong global brands, with Doliprane notably benefiting from advertising via satellite TV channels that air in Algeria. This is the leading brand in overall analgesics, accounting for 16% share in the year. The company also benefits from operating production facilities in Algeria, enabling it to offer affordable prices.

Full Report Details at
- http://www.fastmr.com/prod/1014907_analgesics_algeria.aspx?afid=301

Industry Prospects

Analgesics is expected to benefit from a number of factors in the forecast period. This product category is expected to see ongoing growth in domestic production volumes, with domestic players such as Saidal continuing to expand production capacity. There is also expected to be an increase in foreign direct investment in analgesic production in the country, with the leading domestic players seeking to expand the range of brands they produce under licence. The supply shortages seen during the review period are thus unlikely to be repeated in the forecast period.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Algeria with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Algeria, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Algeria market research report includes:

* Analysis of key supply-side and demand trends
* Detailed segmentation of international and local products
* Historic volumes and values, company and brand market shares
* Five year forecasts of market trends and market growth
* Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

* What is the market size of Analgesics in Algeria?
* What are the major brands in Algeria?
* Are combination products with acetaminophen still popular?

Reasons to Get this Report

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Analgesics in Japan
- Analgesics in Denmark
- Analgesics in New Zealand
- Analgesics in Ireland
- Analgesics in France